Oracle’s Credit Market Alarm Rings Louder Than a Single-Day Stock Bounce
Published on 07/22/2026 at 06:12 | Redaktion boerse-global.de
Oracle shares clawed back some ground on Tuesday, rising 4.95 percent to close at €111.60 in European trading, after hitting a fresh 52-week low of €105.10 just a day earlier. But the move does little to mask the deeper stresses building beneath the surface. The stock remains 26.39 percent below its 50-day moving average and more than 30 percent below the 200-day line, while the real warning signals are flashing not in equities, but in the bond market.
The five-year credit default swap spread on Oracle debt surged to 198.23 basis points last week, according to ICE Data Services, eclipsing the prior record of 198.18 basis points set on March 27. That jump of roughly 10 basis points followed S&P Global’s downgrade of the company’s credit rating, leaving Oracle just one notch above junk territory. With roughly $117 billion in bonds sitting in the US investment-grade index, any further deterioration carries implications far beyond a single name. Moody’s maintains a negative outlook on Oracle, keeping the door open to additional downgrades.
The credit market’s anxiety traces directly back to the staggering cost of Oracle’s artificial intelligence infrastructure buildout. The company spent $55.7 billion on capital expenditures in the fiscal year through May, up from $21.2 billion the prior year. S&P expects that figure to land between $90 billion and $95 billion in the current fiscal year, while the deficit in free operating cash flow is projected to widen to roughly $42 billion. That gap is what makes Oracle’s planned $20 billion equity offering — flagged for the second half of the year — so pivotal. If the capital raise comes at a price well below last year’s highs, existing shareholders face meaningful dilution.
Hedge fund manager Michael Burry weighed in over the weekend to correct reports that he had fully exited his bearish bet against Oracle. “I covered half because I was up,” he wrote on X, calling the liquidation claims “fake news.” Burry sold half of his Oracle put options with a January 2027 expiry, saying the position had grown “too large,” but he retains the remainder. His thesis rests on Oracle’s aggressive spending, questionable financing, and heavy customer concentration — the same factors that have drawn institutional scrutiny following the S&P downgrade.
Should investors sell immediately? Or is it worth buying Oracle?
That concentration is a particular flashpoint. S&P estimates that roughly half of Oracle’s $638 billion in remaining performance obligations — the contractual backlog of future revenue — comes from a single client: OpenAI. If the ChatGPT developer runs into funding trouble meeting its commitments, Oracle could be left with data centers built for demand that never materializes. The company’s cloud revenue jumped 47 percent to $9.9 billion in the latest quarter, and total revenue rose 21 percent to $19.2 billion, but the backlog figure, while spectacular, carries execution risk that the credit markets are already pricing in.
The stock’s technical picture offers little comfort. The 14-day relative strength index sits at 31.1, signaling oversold conditions, and the shares trade 27.65 percent below the 50-day average of €151.57 and 32.09 percent below the 200-day average of €161.48. Tuesday’s gain leaves the stock just 4.34 percent above its 52-week low. The annualized 30-day volatility of 51.15 percent means sharp daily swings are possible without any real change in the underlying trend.
The bull case rests on that $638 billion backlog eventually converting into cash flow, and on the company’s stated commitment to defending its investment-grade rating through a mix of debt and equity. Analysts’ average price target of €220.62 implies nearly double the current share price. But the bear case points to execution risk and a financing trap: if the investment pace keeps accelerating, more dilutive capital may be needed beyond the announced $20 billion. The credit markets are already voting with their wallets — the five-year CDS spread hit an 18-year high — and Moody’s has kept its negative outlook in place.
Oracle at a turning point? This analysis reveals what investors need to know now.
The next concrete test comes with Oracle’s fiscal first-quarter results for 2027, due in the coming months. Those numbers will show whether free cash flow is improving and what form the capital increase ultimately takes. Until then, the chasm between a record backlog and a widening funding gap is likely to keep the stock volatile in both directions. Burry’s remaining short position, and the credit market’s historic anxiety, serve as reminders that a single-day bounce does not a recovery make.
Ad
Oracle Stock: New Analysis - 22 July
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
